| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |